I just read the report in more detail.
There are lots of positives in there too.
PromarkerD will be launched across Australia at the Australasian Diabetes Congress, 20-22 August,
Gold Coast, and
Promarker®Eso will be launched at the 21st International Society for Diseases of the Esophagus (ISDE)
World Congress, 18-20 September, Brisbane. I would imagine they are going straight to an Australia wide release given the launch in Brisbane?
PromarkerEndo is still being slated for release before the end of 2025, and in addition, Partnering discussions are advancing in key markets for licensing in women’s health and fertility.
Milesy
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.56M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $21.93K | 59.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 11.52am 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |